Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Cutting Through Complexity as CEO
Nick Elliott, CEO of AWE Nuclear Security Technologies, talks to Criticaleye’s Jacob Ambrose Willson about why the biggest, most complex projects are the most rewarding. A common theme that runs throughout...
HR Leaders At The Top Table: Robert Chong on the Evolving Role of the CPO
Robert Chong, Senior Advisor for Sembcorp Industries and a Criticaleye Board Mentor speaks to Criticaleye Senior Editor Bridgette Hall about the evolving role of the CHRO in Asia and if HR leaders are adapting and eq...
How to Execute a Successful Exit with Paul Lester CBE
A successful exit is rarely defined by valuation alone. Behind every strong outcome is strategic preparation, disciplined leadership and an organisation that is ready for transition. In this episode of Criticaley...
Displaying 1 to 3 of 205
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
